Ultragenyx Pharmaceutical (RARE) Assets (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Assets of $1.26 billion in Q2 2026, down 3.2% from $1.31 billion a year earlier and down 2.5% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical reported Assets of $1.53 billion, up 1.9% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $1.5 billion in FY2024 (+0.8%), $1.49 billion in FY2023 (-3.5%), $1.55 billion in FY2022 (+1.5%) and $1.52 billion in FY2021 (-13.5%).
- Quarterly Assets has ranged from $1.19 billion in Q3 2025 to $1.62 billion in Q3 2022 over the past five years.
- On a year-over-year basis, Assets rose in four of the last eight quarters, with an average decline of 2.4%.
- Peak year-over-year performance for Assets in the last five years was growth of 24.2% in Q3 2024, against a decline of 23.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.3 billion (Q1 2026), $1.53 billion (Q4 2025) and $1.19 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | 1.26 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 1.30 Bn |
| Dec 31, 2025 | 1.53 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 1.54 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.38 Bn |
| Dec 31, 2022 | 1.55 Bn |
| Sep 30, 2022 | 1.62 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.48 Bn |
API Access
Ultragenyx Pharmaceutical Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();